BMRN BioMarin Pharmaceutical, Inc.
$56.12
BioMarin Pharmaceutical, Inc. (BMRN) Earnings News
Earnings press releases, previews and reviews for BioMarin Pharmaceutical, Inc. (BMRN), newest first. Our most recent is review: BioMarin Tops Depressed EPS Bar and Crosses $1 Billion, but a Guidance Cut and Softer VOXZOGO Trends Complicate the Story.
Monday
November 2, 2026
6:22 PM ET
BioMarin Tops Depressed EPS Bar and Crosses $1 Billion, but a Guidance Cut and Softer VOXZOGO Trends Complicate the Story
Earnings Whispers · Review
Monday
November 2, 2026
4:03 PM ET
BioMarin Reports Third Quarter 2026 Financial and Operating Results
Monday
October 26, 2026
11:54 AM ET
BioMarin Must Prove Voxzogo Can Hold Ground as Amicus Lifts Revenue Toward $1 Billion
Earnings Whispers · Preview
Monday
October 26, 2026
9:00 AM ET
BioMarin to Host Third Quarter 2026 Financial Results Conference Call and Webcast on Monday, November 2, 2026, at 4:30pm ET
Thursday
August 6, 2026
4:03 PM ET
BioMarin Reports Second Quarter 2026 Financial and Operating Results
Thursday
July 30, 2026
9:00 AM ET
BioMarin to Host Second Quarter 2026 Financial Results Conference Call and Webcast on Thursday, August 6, 2026, at 4:30pm ET